OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ)

CUSIP: 686164302

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM NEW
Total 13F shares
6,084,274
Share change
-773,284
Total reported value
$17,641,000
Put/Call ratio
186%
Price per share
$2.90
Number of holders
38
Value change
-$2,467,313
Number of buys
10
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 686164302?
CUSIP 686164302 identifies OREXQ - OREXIGEN THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ) as of Q2 2017

As of 30 Jun 2017, OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,084,274 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, BVF INC/IL, Foresite Capital Management II, LLC, Foresite Capital Management III, LLC, NEA Management Company, LLC, VANGUARD GROUP INC, CREDIT SUISSE AG/, BlackRock Inc., Old West Investment Management, LLC, and Rock Springs Capital Management LP. This page lists 38 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.